Obesity Medicine

Obesity medication is the field of pharmaceutical devoted to the far-reaching consideration of patients with obese. It is the field of medicine committed to the absolute care of patients with obesityObesity Medicine target on health and disease, relating to the very broad spectrum of research in and strike on humans.Obesity medicine clinicians who are individuals from the Obesity Medicine Association   use an exhaustive, logical, and individualized approach involved nutrition, physical activity, conduct treatment, and prescription to enable patients to get more fit and accomplish better general health.

  • Contrave (naltrexone HCl and bupropion HCl) ; Takeda Pharmaceuticals U.S.A.; For chronic weight management , Approved September 2014
  • Jardiance (empagliflozin) ; Boehringer Ingelheim; For the treatment of type II diabetes, Approved August 2014
  • Saxenda (liraglutide [rDNA origin] injection); Novo Nordisk; For chronic weight management, Approved December 2014
  • Tanzeum (albiglutide); GlaxoSmithKline; For the treatment of type II diabetes mellitus, Approved April 2014
  • Trulicity (dulaglutide); Eli Lilly; To improve glycemic control in type II diabetics, Approved September 2014
  • Nesina (alogliptin); Takeda; For the treatment of type II diabetes mellitus, Approved January 2013
  • Belviq (lorcaserin hydrochloride); Arena Pharmaceuticals; For the chronic management of weight loss, Approved June 2012
  • Bydureon (exenatide extended-release for injectable suspension); Amylin; For the improvement of glycemic control in adults with type II diabetes mellitus, Approved January 2012
  • Qsymia (phentermine + topiramate extended-release); Vivus; For the treatment of chronic weight management, Approved July 2012

Related Conference of Obesity Medicine

July 26-27, 2018

European Food Chemistry and Eating Disorder Congress

Venue: HYATT PLACE AMSTERDAM AIRPORT
August 24-25, 2018

20th Global Obesity Meeting

Singapore
August 28-29, 2018

17th International Conference on Obesity, Diet and Nutrition

Paris, France. Venue: Holiday Inn Paris – Marne La Vallee

Dallas, Texas, USA
September 13-14, 2018

14th Euro Obesity and Endocrinology Congress

London, UK
September 21-22, 2018

17th World Congress on Obesity & Nutrition

Osaka, Japan
October 25-26, 2018

21st World Obesity Conference

Budapest, Hungary
November 29-30, 2018

International Conference on Obesity and Diet Imbalance

Bali, Indonesia

Obesity Medicine Conference Speakers

Recommended Sessions

Related Journals

Are you interested in